COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 2908: Articles 29071-29080  | Next

A Modular Framework for Multiscale Spatial Modeling of Viral Infection and Immune Response in Epithelial Tissue
Sego, T. J., Aponte-Serrano, J. O., Ferrari-Gianlupi, J., Heaps, S., Quardokus, E. M., Glazier, J. A.
10.1101/2020.04.27.064139 — Posted: 2020-04-28
Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the surface protein (spike) S1 receptor binding domain with heparin.
Mycroft-West, C., Su, D., Pagani, I., Rudd, T., Elli, S., Guimond, S., Miller, G., Meneghetti, M., Nader, H., Li, Y., Nunes, Q., Procter, P., Mancini, N., Clementi, M., Bisio, A., Forsyth, N., Turnbull, J., Guerrini, M., Fernig, D., Vicenzi, E., Yates, E., Lima, M., Skidmore, M. A.
10.1101/2020.04.28.066761 — Posted: 2020-04-28 Discussion: Onsite
Variation in COVID-19 Outbreaks at U.S. State and County Levels
Messner, W., Payson, S. E.
10.1101/2020.04.23.20076943 — Posted: 2020-04-28
Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2 Infection
Cholankeril, G., Podboy, A., Aivaliotas, V., Pham, E. A., Tarlow, B., Spencer, S., Kim, D., Hsing, A., Ahmed, A.
10.1101/2020.04.23.20076935 — Posted: 2020-04-28
Facing the COVID-19 epidemic in NYC: a stochastic agent-based model of various intervention strategies
Hoertel, N., Blachier, M., Blanco, C., Olfson, M., Massetti, M., Limosin, F., Leleu, H.
10.1101/2020.04.23.20076885 — Posted: 2020-04-28 Discussion: Onsite | Offsite
Dataset on the COVID-19 Pandemic Situation in Tunisia with application to SIR Model
Lassoued, A., Ben Saad, A., Lassoued, H., Ketata, R., Boubaker, O.
10.1101/2020.04.23.20076802 — Posted: 2020-04-28
A simple mathematical model for Coronavirus (COVID-19)
El Allaoui, A., Melliani, S., Chadli, L. S.
10.1101/2020.04.23.20076919 — Posted: 2020-04-28
Performing risk stratification for COVID-19 when individual level data is not available, the experience of a large healthcare organization
Barda, N., Riesel, D., Akriv, A., Levi, J., Finkel, U., Yona, G., Greenfeld, D., Sheiba, S., Somer, J., Bachmat, E., Rothblum, G. N., Shalit, U., Netzer, D., Balicer, R., Dagan, N.
10.1101/2020.04.23.20076976 — Posted: 2020-04-28
Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparin-involved treatment
Liu, X., Zhang, X., Xiao, Y., Gao, T., Wang, G., Wang, Z., Zhang, Z., Hu, Y., Dong, Q., Zhao, S., Yu, L., Zhang, S., Li, H., Li, K., Chen, W., Bian, X., Mao, Q., Cao, C.
10.1101/2020.04.23.20076851 — Posted: 2020-04-28
Vitamin D Insufficiency is Prevalent in Severe COVID-19
Lau, F. H., Majumder, R., Torabi, R., Saeg, F., Hoffman, R., Cirillo, J. D., Greiffenstein, P.
10.1101/2020.04.24.20075838 — Posted: 2020-04-28 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).